DELPHI GENETICS - DELPHI GENETICS YOUR CERTIFIED CDMO PARTNER FOR GMP PLASMID DNA BIOPRODUCTION

Belgique

Office Building Outline icon Prestataire de services

DELPHI GENETICS
Web icon

Aperçu du catalogue produits

Belgique

With thousands of DNA vectors designed and constructed, Delphi Genetics is a Partner of choice to generate your plasmid of interest. Size does not matter, that's the strategy of cloning that drives the success of a plasmid construction. We perform the construction of your vector from strategy design to final plasmid production. We work with standard plasmid DNA as well as with large constructs, such as BAC and Cosmid. Our plasmid DNA construction service includes: Sequences analysis Design and strategy Gene Synthesis Cloning of PCR fragment DNA fragment assembling Site directed mutagenesis DNA sequencing Plasmid productionA new hope for Covid-19 treatment Delphi Genetics more than triples its production capacity and receives GMP certification. New Plasmid DNA production capacities now immediately available. Delphi to attend Phacilitate Leaders World in Miami, Jan 21-24 Delphi Genetics significantly expands its capacities for cGMP plasmid DNA GMP Certification for Plasmid DNA

Demander un devis

Belgique

Delphi Genetics provides customized plasmid DNA production services, from milligram to gram scale, for your R&D and clinical activities. We take care of your plasmid DNA material for viral vectors production and naked DNA-based gene therapy. Our service includes the supply of: R&D grade for non-clinical use, support for lead identification, clone screening, STABY evaluation. High Quality and GMP grade plasmid DNA for viral and non-viral (pre-)clinical activities.

Demander un devis

Belgique

GMP grade plasmid DNA production is based on robust, single-use, TSE-BSE-free methods and occurs in our GMP suite, at a maximum scale of 50L. Delphi Genetics offers one-stop-shop CDMO service for plasmid DNA GMP supply, including: GMP compliant Process and QC Development GMP E.coli cell banking (Master and Working Cell Banks) GMP DNA Manufacturing using TSE-BSE free and Single-use process, based on QP approved Master Batch Record QC and Release by Qualified Person (QP) Full Quality Control complying with the European pharmacopea 5.14 will be performed: Content and purity by UV measurement (260/280 nm) Visual inspection Identity by restriction and DNA sequencing (full plasmid sequencing) Safety tests: Endotoxins, Bioburden/Sterility and Mycoplasma Residual RNA content Residual host protein Residual host genomic by Q-QPCR pH Topology Other tests can be performed on request. QP Released GMP Plasmid DNA is provided with TSE-BSE-free certificate and Certificate of Analysis.

Demander un devis

Belgique

High-Quality grade plasmid DNA production is based on robust, single-use, TSE-BSE-free methods and occurs in our GMP suite, at a maximum scale of 50L, after Delphi's process performance assessment. Full Quality Control complying with the European pharmacopea 5.14 will be performed: Content and purity by UV measurement (260/280 nm) Visual inspection Identity by restriction and DNA sequencing (full plasmid sequencing) Safety tests: Endotoxins, Bioburden/Sterility and Mycoplasma Residual RNA content Residual host protein Residual host genomic by Q-QPCR pH Topology Other tests can be performed on request. High quality Plasmid DNA is provided with TSE-BSE-free certificate and Certificate of Analysis.

Demander un devis

Delphi Genetics est une entreprise de biotechnologie, fondée en 2001, basée à Charleroi, dans le Biopark de Gosselies en Belgique. Delphi Genetics est une CDMO (pour Contract Development & Manufacturing Organization) spécialisée dans le génie génétique et la bioproduction d’ADN plasmidique, pour des études cliniques de thérapie génique virale et non virale. Fort de 20 ans d’expertise en R&D, nous avons à cœur d’apporter des technologies et solutions personnalisées et innovantes pour favoriser le développement de nouvelles thérapies. Nous proposons un service « one-stop-shop » permettant, d’une part de contribuer à la sélection de nouveaux candidats ADN plasmidique, et d’autre part de fabriquer ces mêmes plasmides en conditions BPF pour évaluation clinique et commerciale. Les plasmides produits sont utilisés pour la fabrication de vecteurs viraux (AAV, Lentivirus…), d’ARN messager, ou à des fins vaccinales. Nous avons également mis au point une technologie innovante et brevetée (Staby®) pour la bioproduction, sans antibiotique, de plasmides et protéines recombinantes en cellule E.coli. Notre technologie augmente considérablement la stabilité de l'ADN plasmidique dans les souches hôtes, ce qui se traduit par une amélioration globale du rendement de production et de la reproductibilité. Elle constitue ainsi une bonne alternative aux gènes standard de résistance aux antibiotiques et répond à la demande régulatoire. N'hésitez pas à nous contacter pour plus d'informations !

Dernières actualités de l'entreprise

CATALENT TO ACQUIRE DELPHI GENETICS

CATALENT TO ACQUIRE DELPHI GENETICS

Dernière réalisation ・ 23 févr. 2021

SOMERSET, N.J. and GOSSELIES, BELGIUM – February 23, 2021 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based in Gosselies, Belgium, today announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics. Catalent is also announcing the launch of pDNA development and manufacturing services at its Rockville, Maryland facility. Together, the addition of pDNA technology and production capabilities marks a significant milestone for Catalent Cell & Gene Therapy. https://www.catalent.com/catalent-news/catalent-to-acquire-delphi-genetics-and-launch-us-plasmid-manufacturing-site-to-establish-global-pdna-development-and-manufacturing-capabilities/

Documents

Domain icon Prestataire de services

DELPHI GENETICS

Rue A. de Saint-Exupéry, 5

6041 Gosselies - Belgique

N° de TVA
Contacter

Infos entreprise

Chiffres clés

  • Effectif
    11 – 50
  • Commerciaux
    1 – 10

Organisation

  • Année de création
    2001
  • Nature de l'entreprise
    Siège social – Maison-mère
  • Activité principale
    Prestataire de services

Activités de DELPHI GENETICS

  • Bio-chimie, environnement - études et recherches
  • Biopharmacie
  • production d'ADN plasmidique
  • CDMO
  • Développement d'ADN plasmidique
Office Building Outline icon
Une page pour votre entreprise
Vous voyez ceci ? Vos clients potentiels aussi. Rejoignez-nous pour être visible sur europages.

Demande de devis

Créez une seule demande et obtenez plusieurs devis de fournisseurs vérifiés.

  • Fournisseurs qualifiés
  • Respect de la vie privée
  • 100% gratuit